Brd2 Inhibits Adipogenesis via the ERK1/2 Signaling Pathway in 3T3-L1 Adipocytes

Eosinophils in the Spotlight: Finding the link between obesity and asthma

(2013) Clare M Lloyd et al.   NATURE MEDICINE

c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway

(2011) J. Rauch et al.   CANCER RESEARCH

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

(2011) Jake E. Delmore et al.   CELL

The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic

(2011) B. A. Neel et al.   DIABETES

Obesity and Dyslipidemia

(2011) Remco Franssen et al.   MEDICAL CLINICS OF NORTH AMERICA

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

(2011) Johannes Zuber et al.   NATURE

Mechanisms linking obesity to hypertension

(2011) J. A. N. Dorresteijn et al.   Obesity Reviews

Targeting MYC dependence in cancer by inhibiting BET bromodomains

(2011) J. A. Mertz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF

(2010) Y.-T. Chou et al.   CANCER RESEARCH

Genomics, Type 2 Diabetes, and Obesity

(2010) Mark I. McCarthy   NEW ENGLAND JOURNAL OF MEDICINE

Obesity, weight loss and conditional cardiovascular risk factors

(2010) T. Tzotzas et al.   Obesity Reviews

Brd2disruption in mice causes severe obesity without Type 2 diabetes

(2009) Fangnian Wang et al.   BIOCHEMICAL JOURNAL

Genetics of Common Obesity and Nonalcoholic Fatty Liver Disease

(2009) Elizabeth K. Speliotes   GASTROENTEROLOGY

Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators and show structural and expression divergence

(2008) Angela J DiBenedetto et al.   BMC DEVELOPMENTAL BIOLOGY